1. Home
  2. AISP vs CNTX Comparison

AISP vs CNTX Comparison

Compare AISP & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airship AI Holdings Inc.

AISP

Airship AI Holdings Inc.

HOLD

Current Price

$3.14

Market Cap

112.1M

Sector

Finance

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$1.62

Market Cap

116.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AISP
CNTX
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.1M
116.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AISP
CNTX
Price
$3.14
$1.62
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$5.67
AVG Volume (30 Days)
828.4K
1.6M
Earning Date
03-02-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,033,886.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$216.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.71
$0.49
52 Week High
$7.20
$2.00

Technical Indicators

Market Signals
Indicator
AISP
CNTX
Relative Strength Index (RSI) 47.78 65.96
Support Level $3.05 $1.46
Resistance Level $3.34 $1.79
Average True Range (ATR) 0.21 0.17
MACD 0.05 0.02
Stochastic Oscillator 67.20 56.59

Price Performance

Historical Comparison
AISP
CNTX

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: